603669 靈康藥業
按盤價 
4.540 -0.020 (-0.439%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -4.585 | -15.377 | -14.668 | -15.104 | 4.485 |
| 總資產報酬率 ROA (%) | -2.809 | -9.081 | -8.707 | -8.964 | 2.520 |
| 投入資產回報率 ROIC (%) | -3.304 | -10.029 | -9.094 | -9.260 | 2.622 | 邊際利潤分析 |
| 銷售毛利率 (%) | 43.923 | 46.881 | 46.672 | 67.809 | 79.376 |
| 營業利潤率 (%) | -13.234 | -33.906 | -75.690 | -65.226 | 9.608 |
| 息稅前利潤/營業總收入 (%) | -6.824 | -33.207 | -76.447 | -65.670 | 10.385 |
| 淨利潤/營業總收入 (%) | -12.241 | -34.431 | -76.967 | -67.711 | 8.902 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 134.234 | 67.780 | 103.963 | 89.066 | 48.031 |
| 價值變動淨收益/利潤總額(%) | -4.208 | 5.339 | 9.628 | 4.300 | 23.916 |
| 營業外收支淨額/利潤總額(%) | -8.115 | -0.814 | 1.308 | 0.069 | -0.920 | 償債能力分析 |
| 流動比率 (X) | 3.110 | 2.675 | 3.626 | 3.743 | 2.756 |
| 速動比率 (X) | 2.801 | 2.548 | 3.393 | 3.581 | 2.676 |
| 資產負債率 (%) | 38.787 | 38.681 | 42.690 | 38.849 | 41.980 |
| 帶息債務/全部投入資本 (%) | 27.851 | 26.498 | 39.190 | 36.010 | 39.555 |
| 股東權益/帶息債務 (%) | 256.361 | 274.441 | 153.346 | 176.783 | 150.667 |
| 股東權益/負債合計 (%) | 157.815 | 158.526 | 134.249 | 157.405 | 138.208 |
| 利息保障倍數 (X) | -1.260 | -78.049 | -310.910 | 164.745 | 12.006 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 258.181 | 145.938 | 143.506 | 134.245 | 71.707 |
| 存貨周轉天數 (天) | 72.597 | 75.527 | 181.612 | 194.865 | 142.329 |
| 備註： | 即時報價更新時間為 17/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
